Carisma Therapeutics Inc.

CARM · OTC · SIC 2834: Pharmaceutical Preparations
350
SEC Filings

Business Summary

Carisma Therapeutics Inc. is a biotechnology company focused on macrophage and monocyte engineering to develop therapies for liver fibrosis and cancer. Its proprietary CAR-M platform uses chimeric antigen receptors to redirect macrophages against tumor-associated antigens. Key candidates include CT-2401 (liver fibrosis, mRNA/LNP approach) and CT-1119 (mesothelin-positive solid tumors). Following strategic reviews in 2024-2025, the company paused R&D and is exploring strategic alternatives including asset sales, partnerships, or a company merger.

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCARMdiscussed_in_filing Cybersecurity
topic_mentionCARMdiscussed_in_filing Trusted Computing
topic_mentionCARMdiscussed_in_filing Blockchain & Crypto
topic_mentionCARMdiscussed_in_filing Capital Expenditure
topic_mentionCARMdiscussed_in_filing Regulation
topic_mentionCARMdiscussed_in_filing Healthcare & Bio
topic_mentionCARMdiscussed_in_filing Platform & Ecosystem
topic_mentionCARMdiscussed_in_filing Sovereign & Government
topic_mentionCARMdiscussed_in_filing Cybersecurity
topic_mentionCARMdiscussed_in_filing Trusted Computing
topic_mentionCARMdiscussed_in_filing Blockchain & Crypto
topic_mentionCARMdiscussed_in_filing Capital Expenditure
topic_mentionCARMdiscussed_in_filing Regulation
topic_mentionCARMdiscussed_in_filing Healthcare & Bio
topic_mentionCARMdiscussed_in_filing Platform & Ecosystem
topic_mentionCARMdiscussed_in_filing Sovereign & Government
topic_mentionCARMdiscussed_in_filing Cybersecurity
topic_mentionCARMdiscussed_in_filing Trusted Computing
topic_mentionCARMdiscussed_in_filing Blockchain & Crypto
topic_mentionCARMdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-03-312024-12-310001628280-25-015673EDGAR105K words
2024-04-012023-12-310001485003-24-000005EDGAR—
2023-02-282022-12-310001485003-23-000090EDGAR—
2022-02-282021-12-310001485003-22-000033EDGAR—
2021-03-152020-12-310001485003-21-000044EDGAR—
2020-03-162019-12-310001485003-20-000038EDGAR—
2019-03-012018-12-310001485003-19-000015EDGAR—
2018-04-022017-12-310001485003-18-000034EDGAR—
2017-03-242016-12-310001485003-17-000018EDGAR—
2016-03-252015-12-310001485003-16-000068EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001104659-25-110444EDGAR23K words
2025-08-072025-06-300001628280-25-038922EDGAR—
2025-05-132025-03-310001628280-25-025144EDGAR—
2024-11-072024-09-300001485003-24-000020EDGAR—
2024-08-082024-06-300001485003-24-000015EDGAR—
2024-05-092024-03-310001485003-24-000009EDGAR—
2023-11-092023-09-300001485003-23-000119EDGAR—
2023-08-102023-06-300001485003-23-000116EDGAR—
2023-05-112023-03-310001104659-23-058778EDGAR—
2022-11-072022-09-300001485003-22-000156EDGAR—
2022-08-082022-06-300001485003-22-000108EDGAR—
2022-05-092022-03-310001485003-22-000063EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-12-050001104659-25-118863EDGAR1K words
2025-10-150001104659-25-099740EDGAR—
2025-10-090001104659-25-098404EDGAR—
2025-09-180001104659-25-091064EDGAR—
2025-08-290001104659-25-085705EDGAR—
2025-08-080001104659-25-075680EDGAR—
2025-07-150001104659-25-068098EDGAR—
2025-06-230001104659-25-061397EDGAR—
2025-06-120001104659-25-058622EDGAR—
2025-04-160001104659-25-035517EDGAR—

350 total filings indexed. 318 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

liver-fibrosis-treatment oncology-/-solid-tumor-cancer-therapy cell-and-gene-therapy myeloid-cell-immunotherapy chimeric-antigen-receptor-(car)-technology mrna/lipid-nanoparticle-(lnp)-delivery ex-vivo-cell-engineering in-vivo-macrophage-engineering

Company Identity

CIK0001485003
TickerCARM
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4fa5e6834fe7e4de9f61886d47d62a38750b01caf5b973370f8b23e93d520551
parent: 72345a39aba3116a5a943009ca50720d715ce1122be7fb1229f5a63834643d6e
content hash: dba183145f57536bbff279ebeb0bc2ba901de4c551f9a021196c017f4f072007
signed: 2026-04-13T04:44:11.996Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf